CA2532866A1 - Utilisation de la proteine sahh comme marqueur du cancer colorectal - Google Patents

Utilisation de la proteine sahh comme marqueur du cancer colorectal Download PDF

Info

Publication number
CA2532866A1
CA2532866A1 CA002532866A CA2532866A CA2532866A1 CA 2532866 A1 CA2532866 A1 CA 2532866A1 CA 002532866 A CA002532866 A CA 002532866A CA 2532866 A CA2532866 A CA 2532866A CA 2532866 A1 CA2532866 A1 CA 2532866A1
Authority
CA
Canada
Prior art keywords
sahh
colorectal cancer
diagnosis
protein
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002532866A
Other languages
English (en)
Inventor
Michael Tacke
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Werner Zolg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F. Hoffmann-La Roche Ag
Michael Tacke
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Werner Zolg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag, Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg filed Critical F. Hoffmann-La Roche Ag
Publication of CA2532866A1 publication Critical patent/CA2532866A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002532866A 2003-08-07 2004-08-05 Utilisation de la proteine sahh comme marqueur du cancer colorectal Abandoned CA2532866A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03017554.1 2003-08-07
EP03017554 2003-08-07
PCT/EP2004/008758 WO2005015221A1 (fr) 2003-08-07 2004-08-05 Utilisation de la proteine sahh comme marqueur du cancer colorectal

Publications (1)

Publication Number Publication Date
CA2532866A1 true CA2532866A1 (fr) 2005-02-17

Family

ID=34130051

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002532866A Abandoned CA2532866A1 (fr) 2003-08-07 2004-08-05 Utilisation de la proteine sahh comme marqueur du cancer colorectal

Country Status (3)

Country Link
EP (1) EP1654539A1 (fr)
CA (1) CA2532866A1 (fr)
WO (1) WO2005015221A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2629071A1 (fr) * 2005-12-21 2007-06-28 F. Hoffmann-La Roche Ag Methode d'evaluation du cancer colorectal par mesure de l'hemoglobine et de la pyruvate-kinase m2 dans un echantillon de selles
CN112881692B (zh) * 2021-01-08 2022-11-22 深圳华大基因股份有限公司 一种用于结直肠癌及腺瘤早期筛查的蛋白定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014157A1 (fr) * 1991-02-05 1992-08-20 Kamal Bahar Test simple servant a detecter l'antigene carcino-embryonnaire

Also Published As

Publication number Publication date
EP1654539A1 (fr) 2006-05-10
WO2005015221A1 (fr) 2005-02-17

Similar Documents

Publication Publication Date Title
US7205118B2 (en) Nicotinamide N-methyltransferase as a marker for colorectal cancer
US20060177880A1 (en) Use of PRN3/ILEU as a marker for colorectal cancer
US20060188949A1 (en) Use of protein PLST as a marker for colorectal cancer
US20060121540A1 (en) Use of protein MASP as a marker for colorectal cancer
WO2005015218A1 (fr) Utilisation de la proteinase 3(prn3) et de l'inhibiteur de l'elastase leucocytaire (ileu) en tant que marqueurs pour le cancer colorectal
WO2005095978A1 (fr) Utilisation de la pyrroline-5-carboxylate reductase en tant que marqueur pour le cancer colorectal
WO2004071267A2 (fr) Diagnostic du cancer colono-rectal par detection de nicotinamide n-methyltransferase dans un echantillon de selles
US20060188950A1 (en) Use of protein spee as a marker for colorectal cancer
US20060199232A1 (en) Use of protein PSE3 as a marker for colorectal cancer
CA2532866A1 (fr) Utilisation de la proteine sahh comme marqueur du cancer colorectal
US20060194266A1 (en) Use of protein RLA-0 as a marker for colorectal cancer
WO2005015223A1 (fr) Utilisation de la proteine ribosomale acide p0 (rla-0) comme marqueur dans le cancer colorectal
WO2005015233A1 (fr) Utilisation de la proteine spee (spermidine synthase) comme marqueur du cancer colorectal
WO2005015234A1 (fr) Utilisation de la proteine sahh comme marqueur du cancer colorectal
US20070218510A1 (en) Use of protein PSA3 as a marker for colorectal cancer
WO2005015232A1 (fr) Utilisation de la proteine pse3 (sous-unite activatrice du proteasome 3) comme marqueur du cancer colorectal
WO2005015227A1 (fr) Proteine t-plastine (plst) utilisee comme marqueur du cancer colorectal
WO2004104592A1 (fr) Utilisation de la proteine masp en tant que marqueur pour le cancer colorectal
WO2005015225A1 (fr) Utilisation de la proteine de liaison a element amont eloigne (fuse) (fubp) comme marqueur du cancer colorectal
WO2005015230A1 (fr) Utilisation de la proteine sa3 as comme marqueur du cancer colorectal
WO2005095979A1 (fr) Utilisation de la proteine proc en tant que marqueur pour le cancer colorectal
WO2005015222A1 (fr) Utilisation de la proteine de liaison a element amont eloigne (fuse) (fubp) comme marqueur du cancer colorectal

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued